About Stuart Hwang
Form D filings for ENB Therapeutics in 2023 list Stuart Hwang as director.
Stuart Hwang first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Stuart Hwang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stuart Hwang works with at each company, as listed on that company's latest Form D.
ENB Therapeutics, Inc. · Form D, Oct 3, 2023
SJ
Sumayah Jamal
Executive officer and director
BS
Barbara Schilberg
Director
WO
Walter Olesiak
Director
AS
Albert Sokol
Secretary